| Breakdown | TTM | Mar 2025 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.71B | 8.21B | 7.68B | 6.80B | 6.38B | 9.61B |
| Gross Profit | 653.00M | 640.00M | 889.00M | 640.00M | 392.00M | 753.00M |
| EBITDA | 1.03B | 843.00M | 1.65B | 1.33B | 828.00M | 1.02B |
| Net Income | -1.07B | -888.00M | 519.00M | 911.00M | 36.00M | -164.00M |
Balance Sheet | ||||||
| Total Assets | 16.73B | 19.10B | 21.18B | 27.38B | 15.92B | 16.66B |
| Cash, Cash Equivalents and Short-Term Investments | 629.00M | 1.01B | 787.00M | 736.00M | 894.00M | 777.00M |
| Total Debt | 8.11B | 8.77B | 9.13B | 13.41B | 7.58B | 5.70B |
| Total Liabilities | 14.42B | 16.46B | 16.42B | 23.30B | 14.78B | 13.95B |
| Stockholders Equity | -491.00M | -59.00M | 880.00M | 359.00M | -516.00M | 1.23B |
Cash Flow | ||||||
| Free Cash Flow | -361.00M | -408.00M | -496.00M | -474.00M | -110.00M | 37.00M |
| Operating Cash Flow | -109.00M | -111.00M | 138.00M | 181.00M | 618.00M | 514.00M |
| Investing Cash Flow | -345.00M | -335.00M | 3.79B | -9.23B | -478.00M | -235.00M |
| Financing Cash Flow | 416.00M | 797.00M | -3.93B | 8.91B | 14.00M | -293.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | C$1.01B | 2.39 | 5.72% | 0.14% | -44.78% | -95.84% | |
69 Neutral | C$1.67B | 5.53 | 13.66% | 2.29% | 58.88% | 82.03% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | C$706.47M | 1.64 | 35.97% | 2.20% | -1.35% | 496.34% | |
65 Neutral | C$7.54B | 9.04 | 7.20% | 0.36% | 2.46% | -27.48% | |
49 Neutral | C$823.20M | -14.81 | -6.91% | ― | 333.02% | -196.36% | |
47 Neutral | C$4.25B | -2.93 | 249.84% | 0.71% | -0.16% | -2945.66% |